sharecast

{{ storiesRelated.title }}

Technology
24 Oct
dl valirx aim womens health cancer therapeutics drugs medicine development pharmaceuticals vali rx therapies breast cancer logo
ValiRx forms new majority-owned breast cancer subsidiary

Women’s health and cancer therapeutics company ValiRx announced the formation of a new partially-owned subsidiary, Cytolytix, on Monday, which had signed an intellectual property licence agreement with King's College London (KCL).

24 Oct
dl eneraqua technologies aim water heating energy efficiency service provider social housing developments logo
Eneraqua wins social housing heat pump contract

Energy and water efficiency specialist Eneraqua Technologies announced the award of a contract to deliver ground-source heat pump systems for a new UK social housing client on Monday, to be phased over up to three years.

24 Oct
dl creo medical aim surgical endoscopy medical devices manufacturer supplier logo
Creo Medical signs IP licence deal with CMR Surgical

Surgical endoscopy device company Creo Medical Group has signed a non-exclusive intellectual property licence and a royalty agreement with surgical robotics business CMR Surgical, it announced on Monday, to integrate certain aspects of Creo's technology with the ‘Versius’ surgical robotic system through its ‘powered by Kamaptive’ licensing programme.

24 Oct
dl d4t4 solutions aim data technology computing digital products services solution provider logo
D4T4 ends first half in line with expectations

Data solutions specialist D4T4 said in a trading update on Monday that its first-half results were expected to be in line with management expectations, with revenues of about £8. 1m, up from £7. 5m.

24 Oct
dl proton motor power systems aim fuel cell hybrid engine technology developer logo
Proton Motor Power signs 15-year lease on bigger facility

Fuel cell and electric hybrid technology company Proton Motor Power has signed a 15-year lease agreement for a 13,500 square metre facility, it announced on Monday, to “substantially expand” its manufacturing, testing and development capacity.